0001694665-23-000053.txt : 20230510 0001694665-23-000053.hdr.sgml : 20230510 20230510213152 ACCESSION NUMBER: 0001694665-23-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230508 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bodmer Mark CENTRAL INDEX KEY: 0001738885 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 23908566 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_168376869804261.xml FORM 4 X0407 4 2023-05-08 0 0001694665 Evelo Biosciences, Inc. EVLO 0001738885 Bodmer Mark C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 CSO, President of R&D 1 Common Stock 2023-05-08 4 S 0 68014 0.1255 D 285128 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 16, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices within the range of $0.12 to $0.13, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. /s/ Marella Thorell, Attorney-in-Fact for Mark Bodmer 2023-05-10